Vilon: A Tracking Guide for a Short Khavinson Dipeptide

Vilon is a short synthetic dipeptide — Lys-Glu — from the Khavinson family of bioregulators developed at the St. Petersburg Institute of Bioregulation and Gerontology. Like Thymalin and the other compounds in that lineage, most of the published work is Russian-language and focuses on immune regulation, thymic function, and aging-related endpoints. Translational evidence outside that research group is limited.

What it does

In the Khavinson literature, Vilon is described as a thymus-targeting bioregulator with effects on T-cell function, certain inflammatory markers, and lifespan in animal models. The proposed mechanism involves direct interaction with DNA promoter regions modulating gene expression. The evidence is suggestive rather than conclusive at international standards.

Typical protocol shape

Reported patterns:

• Short courses of 10 to 20 days
• Repeated 2 to 4 times per year in chronic-use protocols
• Subcutaneous or intramuscular in the original work
• Intranasal in some self-experimenter logs

Not a continuous daily protocol.

What to track daily

• Dose, route, site, time
• Energy (1 to 10)
• Sleep quality and total hours
• Mood
• Any acute illness signs
• Side effects at injection site

What to track weekly

• Resting heart rate and HRV
• Training recovery
• Body weight
• Frequency of minor illness over the season

Bloodwork worth doing

Optional but useful:

• CBC with differential
• CRP
• Fasting glucose and HbA1c
• Vitamin D

Baseline before the course, repeat 4 to 8 weeks after.

Realistic expectations

The honest version: you are unlikely to feel dramatic changes from a Vilon course. The published claims sit in slow immune and aging-related endpoints, not next-week energy. If you run it expecting a noticeable subjective shift, you will probably be disappointed and inclined to over-attribute placebo effects. Peptid AI helps mostly by forcing you to look at numbers, not vibes.

Common mistakes

• Treating it as a daily peptide. It is structured as short courses.
• Stacking with Thymalin, Epitalon, and other Khavinson peptides at once. You will not be able to attribute anything.
• No baseline. Without 2 to 4 weeks of pre-course data, you have no comparison.
• Over-interpreting placebo. Short courses with subtle expected effects are a placebo magnet.

A tracking template

• Weeks minus 4 to 0: baseline daily metrics
• Course 1: 15 days on, daily log
• Weeks 3 to 12: off, continue daily tracking
• Course 2: repeat
• Year-over-year comparison of seasonal infection counts and recovery metrics

Safety notes

The Russian peptide bioregulator family has a relatively benign reported safety profile, but international clinical safety data is sparse. Source quality varies widely. Discuss with a physician, particularly if you have autoimmune disease or are immunocompromised.

Peptid AI is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.